Citadel Advisors’s INSU Acquisition Corp. III Class A Common Stock IIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-507,792
Closed -$5.06M 15837
2022
Q3
$5.06M Buy
507,792
+458
+0.1% +$4.53K ﹤0.01% 3848
2022
Q2
$5M Sell
507,334
-499,996
-50% -$4.92M ﹤0.01% 3794
2022
Q1
$9.89M Buy
1,007,330
+2
+0% +$20 ﹤0.01% 2982
2021
Q4
$9.87M Sell
1,007,328
-949
-0.1% -$9.3K ﹤0.01% 3098
2021
Q3
$9.9M Buy
1,008,277
+500,806
+99% +$4.88M ﹤0.01% 3097
2021
Q2
$4.92M Buy
507,471
+1,308
+0.3% +$12.9K ﹤0.01% 4472
2021
Q1
$5.04M Buy
+506,163
New +$5.16M ﹤0.01% 4244

Citadel Advisors's IIII Position: Q4 2022 in Review

Citadel Advisors sold out of INSU Acquisition Corp. III Class A Common Stock (IIII) in Q4 2022, closing a stake of 507,792 shares — an estimated $5.06M sold.

Citadel Advisors first reported a position in IIII in Q1 2021 and held it in 7 quarters. The position peaked at $9.9M in Q3 2021. 0 funds tracked by Wall St. Rank hold IIII as of Q4 2022.

  • Citadel Advisors reported no remaining INSU Acquisition Corp. III Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 507,792 INSU Acquisition Corp. III Class A Common Stock shares in Q4 2022, an estimated $5.06M.
  • Citadel Advisors first reported a position in INSU Acquisition Corp. III Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Citadel Advisors's INSU Acquisition Corp. III Class A Common Stock position peaked at $9.9M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held INSU Acquisition Corp. III Class A Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.